Tower Research Capital »

Zyversa Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Zyversa Therapeutics (ZVSA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Zyversa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Zyversa Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zyversa Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.6k 699 3.76

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Zyversa Therapeutics

Tower Research Capital
Royal Bank of Canada
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Zyversa Therapeutics